ETHINAMATE (cas 126-52-3) (valmid) in dentistry
-
Add time:09/24/2019 Source:sciencedirect.com
A double-blind study with ETHINAMATE (cas 126-52-3) and a placebo was performed, with 114 patients receiving ethinamate and 98 receiving placebo. Ethinamate was judged by both operators and patients to be of definite value. The dosage of ethinamate used in the study was one tablet, 500 mg.
We also recommend Trading Suppliers and Manufacturers of ETHINAMATE (cas 126-52-3). Pls Click Website Link as below: cas 126-52-3 suppliers
Prev:Short communicationA simultaneous plasma level and EEG assessment of an oral hypnotic (ETHINAMATE (cas 126-52-3))
Next:NoteIdentification of ETHINAMATE (cas 126-52-3), Ethchlorvynol, and Methylparafynol) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- ArticlesThe Pharmacology and Toxicology of 'Valmid' (ETHINAMATE (cas 126-52-3), Lilly)09/27/2019
- Scientific EditionAn Investigation of the Possible Potentiation of ETHINAMATE (cas 126-52-3) Activity by Chlorpromazine*09/26/2019
- NoteIdentification of ETHINAMATE (cas 126-52-3), Ethchlorvynol, and Methylparafynol09/25/2019
- Short communicationA simultaneous plasma level and EEG assessment of an oral hypnotic (ETHINAMATE (cas 126-52-3))09/10/2019
- Research ArticlesGLC Determination of ETHINAMATE (cas 126-52-3) and Its Hydroxy Derivative in Biological Fluids09/09/2019
